These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 157374)

  • 1. Human T cell growth factor. I. Optimal conditions for its production.
    Alvarez JM; Silva A; de Landazuri MO
    J Immunol; 1979 Sep; 123(3):977-83. PubMed ID: 157374
    [No Abstract]   [Full Text] [Related]  

  • 2. The suppression of mitogen- and alloantigen-stimulated peripheral blood lymphocytes by cultured human T lymphocytes.
    Maca RD; Bonnard GD; Herberman RB
    J Immunol; 1979 Jul; 123(1):246-51. PubMed ID: 156232
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of the functional activities of human T cells after their interaction with SRBC.
    Silva A; Lopez-Botet M; Alvarez J; de Landazuri MO
    J Immunol; 1981 Feb; 126(2):393-7. PubMed ID: 6450242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients.
    Jerrells TR; Dean JH; Richardson GL; McCoy JL; Herberman RB
    J Natl Cancer Inst; 1978 Oct; 61(4):1001-9. PubMed ID: 151749
    [No Abstract]   [Full Text] [Related]  

  • 5. Independent regulation of granulocyte-macrophage colony-stimulating factor and multi-lineage colony-stimulating factor production in T lymphocyte clones.
    Kelso A; Metcalf D; Gough NM
    J Immunol; 1986 Mar; 136(5):1718-25. PubMed ID: 3512707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactive cloned T cell lines. IV. Interaction of alloantigen and T cell growth factors (TCGF) to stimulate cloned cytolytic T lymphocytes.
    Lutz CT; Glasebrook AL; Fitch FW
    J Immunol; 1981 Jul; 127(1):391-2. PubMed ID: 6453898
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic regulation of T-lymphocyte responsiveness to PHA is independent of culture conditions (author's transl)].
    Stiffel C; Liacopoulos-Briot M; Decreusefond C; Lambert F
    Ann Immunol (Paris); 1979; 130(6):841-8. PubMed ID: 317698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effects of low doses of glucocorticoids: effects on autologous and allogeneic mixed leukocyte reactions.
    Hahn BH; MacDermott RP; Jacobs SB; Pletscher LS; Beale MG
    J Immunol; 1980 Jun; 124(6):2812-7. PubMed ID: 6445384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued growth of functional human T lymphocytes: production of human T-cell growth factor.
    Bonnard GD; Yasaka K; Maca RD
    Cell Immunol; 1980 May; 51(2):390-401. PubMed ID: 6966190
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of lymphokines by murine cortisone-resistant thymocytes, stimulated by concanavalin A. I. Comparison of optimal culture conditions for proliferative response and interleukin-2 production.
    Pajtasz E; Kuśnierczyk P; Kisielow P
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):437-42. PubMed ID: 6608337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of insulin in the response of murine T lymphocytes to mitogenic stimulation in vitro.
    Snow EC; Feldbush TL; Oaks JA
    J Immunol; 1980 Feb; 124(2):739-44. PubMed ID: 6965389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells.
    Gillis S; Crabtree GR; Smith KA
    J Immunol; 1979 Oct; 123(4):1632-8. PubMed ID: 158054
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of immunosuppressive factor(s) by a weakly immunogenic fibrosarcoma T 241.
    Gautam SC
    Anticancer Res; 1983; 3(4):263-8. PubMed ID: 6224458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of concanavalin A-induced human lymphocyte mitogenic factor (Interleukin-2) production by suppressor T lymphocytes.
    Northoff H; Carter C; Oppenheim JJ
    J Immunol; 1980 Oct; 125(4):1823-8. PubMed ID: 6967918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell hybridoma-derived regulatory factors. I. Production of T cell growth factor following stimulation by concanavalin A.
    Schrader JW; Clark-Lewis I
    J Immunol; 1981 Mar; 126(3):1101-5. PubMed ID: 6970213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.
    Bird AG; Hammarström L; Smith CI; Britton S
    Clin Exp Immunol; 1981 Jan; 43(1):165-73. PubMed ID: 6454516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell growth factor: parameters for production.
    Ruscetti FW; Mier JW; Gallo RC
    J Supramol Struct; 1980; 13(2):229-41. PubMed ID: 6972470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte colonies stimulated by different mitogens require diverse culture conditions.
    Tice DG; Davey FR
    Exp Hematol; 1983 May; 11(5):394-401. PubMed ID: 6602061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.